In addition, Isl1 functions as a marker for well-differentiated pancreatic neuroendocrine tumors [41], rhabdomyosarcoma [42], and neuroendocrine tumors [43] and also facilitates neuroblastoma development [44]. This evidence concerns the gene ISL1 and neuroendocrine neoplasm.